Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. - sprookjes - yvandenbroek - TriplyDB

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.

http://www.wikidata.org/entity/Q33401314

about

The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis Miraculous catch by neutrophils NETs Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis.High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies.VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.NET untangled in TMA?ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.Histones link inflammation and thrombosis through the induction of Weibel-Palade body exocytosis.Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura Thrombotic Thrombocytopenic Purpura: Pathogenesis, Diagnosis, and Potential Novel Therapeutics.Thrombosis: tangled up in NETs.NETosis: a new factor in tumor progression and cancer-associated thrombosis Increased Nucleosomes and Neutrophil Activation Link to Disease Progression in Patients with Scrub Typhus but Not Murine Typhus in Laos Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study Procoagulant role of neutrophil extracellular traps in patients with gastric cancer.Neutrophil extracellular traps - the dark side of neutrophils.Neutrophils release extracellular DNA traps during storage of red blood cell units Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.Plasma DNA is Elevated in Patients with Deep Vein Thrombosis Nucleosomes and neutrophil activation in sickle cell disease painful crisis.Neutrophil Extracellular Traps and Systemic Lupus Erythematosus.Circulating histones are major mediators of systemic inflammation and cellular injury in patients with acute liver failure.Extracellular DNA traps released by acute promyelocytic leukemia cells through autophagy Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.Neutrophil extracellular traps in cancer progression.Antithrombotic therapy: new areas to understand efficacy and bleeding.Neutrophil extracellular traps: a walk on the wild side of exercise immunology.NETopathies? Unraveling the Dark Side of Old Diseases through Neutrophils.Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation.Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis.Patients with HBV-related acute-on-chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation.ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways.Clinical Efficacy of Andrographolide Sulfonate in the Treatment of Severe Hand, Foot, and Mouth Disease (HFMD) is Dependent upon Inhibition of Neutrophil Activation.

P2860

Q26742171-207AC4CD-5827-4047-88A3-56395B87E71D Q26851914-A0EDE5AA-1A23-41FE-8296-E12A344AC707 Q26852032-5FCA7014-2BDE-4588-86E4-4722A47B07FD Q28069228-B6A22522-336D-411A-BAF5-50CEA4FECC01 Q33402499-885B0360-56D1-4F86-9782-C8988D3E5E52 Q33407984-C3C43DF8-F807-42DF-9CBC-FBC8A785B27F Q33412212-E7A74789-4903-4AB1-857E-49479C8D8569 Q33418811-F2220960-6CFD-49C0-95B2-558115A27A6F Q33419324-4B4A5628-1E3E-462A-80C1-50479A1AE3F5 Q33420968-5CB4D23C-1D01-46AB-BA67-2A57EFB08A2F Q33421220-CD009806-CCDE-44A6-8100-6C2C938479EB Q33427651-F3618B8A-BA0F-42FF-9736-4507B082DF98 Q33435117-7B034A7D-FAA5-46C7-82E9-FBB583F74B75 Q33435545-FB32C251-AE08-4D19-B852-7B570172167E Q33443111-49AF31BF-B5BB-43AD-BA71-1B070417B5BC Q33556910-D67E2C9D-769A-4866-A329-66E5CC837A6E Q33957938-448C844D-2AED-4427-ACA1-765DF7646960 Q35758663-04C4DBCD-7043-440D-A16A-19E1EAC84B24 Q35913208-D7C5D179-867F-49C2-8827-A5FB613F0349 Q35923274-7E3DEC0E-5B1D-4265-AB20-90EB987DC344 Q36464340-BEBB46D0-BF14-4EDF-9293-4A4903C35399 Q36867309-BA59ADA5-03AD-47D2-9E8C-2D43CA4C3B07 Q37057078-C8822B3A-F9A6-4391-A169-905732826FA3 Q37076408-D4960F3D-19C0-4F90-A671-A8A6CD9FC641 Q37262537-AFAE95D3-2EC6-43D8-A239-8A8D3CB1E1ED Q37273218-3E4B1E2B-EE72-44C9-8373-2EEF58C775C0 Q37306015-E473BD3A-CFF6-4160-89E6-4C77EC3A514E Q37330936-9E565A14-3E96-4BE7-93F8-9C11EF5E0C67 Q37412545-2D46F543-0536-4897-A6E5-F94C2AA93E40 Q38132090-0F1ED0E6-35BC-4736-BD64-069AC38992BD Q38234749-0F2F21F2-75F9-4E27-862B-A0AB4A262CF5 Q38262961-E881C553-EEEF-4EDE-A4EF-5BFEAC208810 Q38287683-2B1ED80A-5FD7-411B-AAAF-FE1AC1CE9196 Q38998709-D18C5601-B65F-429E-A4B8-9B577D8D6C71 Q39032748-3118E64C-B131-48DD-94F4-8AF657CDC737 Q39307644-2A6E1AB7-B480-4093-BE83-E7E26B403D20 Q39359763-1FBADB1B-84D5-43CD-9646-8C24C78719AC Q40107341-3BF4794C-F172-401C-89CF-4D1A5EDA4269 Q40171437-449753C0-80F8-4AA0-BFC3-7E17B678CB47 Q40954528-0B492B36-511B-4BEA-B025-850BD9243A00

P2860

Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.

http://www.wikidata.org/entity/Q33401314

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@ast

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@en

type

label

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@ast

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@en

prefLabel

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@ast

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@en

P1433

Q33401314-A0F642EC-E334-42F0-82DE-348065B11C6C

P1476

Q33401314-10BA3E9C-41D0-4139-956C-14A827EDF183

P2093

Q33401314-14FB274A-2588-406B-AA18-49603DA658E3

Q33401314-85EE4C30-2B52-4BB5-984C-5D2DCF34062A

Q33401314-C9716143-98EE-4913-A0D5-FF2F3C66AC10

P2860

Q33401314-046593D3-7ADA-46C2-BD62-E346C9C883E2

Q33401314-159ABAAB-27A7-4FFF-AEF5-59818E3A186F

Q33401314-199F8A7D-92CB-484B-B366-8C3F1578F360

Q33401314-1EE9FCC7-1E5B-4A9D-9FD7-4FCFB1066BE5

Q33401314-1F8514DF-9CD1-4323-8C31-F14AA252F3DA

Q33401314-25109B0C-231F-4116-A7A9-FF23005E9BC6

Q33401314-3124B2A1-550E-438E-9B65-C5FBAF6DD142

Q33401314-3D20786F-0A32-48A5-B456-80EB18B79D5E

Q33401314-3D801E27-7F0A-4506-8388-476ACA3E7A49

Q33401314-47CE680C-D528-4CE1-B8C7-ABC1CEDB9C22

P304

Q33401314-0DAD46E6-4E76-46C3-ABD6-76A807CF3684

P31

Q33401314-C545B62B-9F08-4022-9E1B-AEA8A979E017

P356

Q33401314-E3FAB5D3-8D72-47AA-B461-E84EB6FFF45C

P407

Q33401314-B0DCFC28-92E8-4EBA-96F5-EE2C04824B9A

P433

Q33401314-79064667-E1B1-4DF0-9110-6774B815FF5E

P478

Q33401314-412F9AD2-B5B8-4296-936F-FE7265B49E95

P50

Q33401314-605FCAC5-98B9-4848-9F4B-8E7803153AA8

Q33401314-A00401E4-E337-4D0C-B484-547CFC6794D2

P577

Q33401314-F317636A-CFF5-430F-AEE3-1061C62EAC62

P698

Q33401314-6A4277D7-5E75-4A00-AB3B-2C18CB175EE3

P932

Q33401314-A155B0EA-D716-4F54-92A6-07CCBF270856

P356

BLOOD-2012-02-412197

P1433

P1476

Circulating DNA and myeloperox ...... thrombotic microangiopathies.

@en

P2093

Daphne Schatzberg

http://www.w3.org/2001/XMLSchema#string

Denisa D Wagner

http://www.w3.org/2001/XMLSchema#string

Tobias A Fuchs

http://www.w3.org/2001/XMLSchema#string

P2860

Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

Neutrophil extracellular traps promote deep vein thrombosis in mice

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

Extracellular DNA traps promote thrombosis.

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

Pathogenesis of thrombotic microangiopathies

How neutrophils kill microbes

Neutrophil extracellular traps kill bacteria

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

P304

1157-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-02-412197

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Bernhard Lämmle

Johanna A Kremer Hovinga

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22611154

http://www.w3.org/2001/XMLSchema#string

P932

3418712

http://www.w3.org/2001/XMLSchema#string